Rapid HIV Tests for Women Late in Pregnancy and During Labor

Stopped early

Conditions studied: HIV Infections

In brief

This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.

Key facts

Study ID

NCT00046436

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

7500

Expected to finish

2004-03-01

Last updated by the study team

2013-06-03

Who can join

Age: 13 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Late Presenter Group:
• Unknown HIV serostatus
• >= 34 weeks gestation
• Peripartum Group:
• Unknown HIV serostatus
• >= 24 weeks gestation
• In active labor or delivery expected within 24 hours
• Infants:
• Maternal Step I enrollment
• Positive maternal OraQuick and/or EIA/Western blot result

You may not qualify if…

• Late Presenter Group:
• Previous or current antiretroviral therapy for treatment of HIV infection
• In active labor
• Evidence of ruptured membranes
• Peripartum Group:
• Previous or current antiretroviral therapy for treatment of HIV infection

Where it is running

• Univ. of Pennsylvania Health System, Hosp. of the Univ. of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.